Packaging is one of the most important component of the product. Packaging in pharmaceuticals is crucial and important to drug stability. Packaging of pharmaceuticals ensures the protection of the product from various factors such as moisture, sunlight, and other environmental factors. This in turn inhibits microbial growth and consequently extends the shelf life of the drug. Parental drugs are administered in the body other than oral or rectal. Common parental drug administration sites are intravenous, intramuscular, or subcutaneous. Parental drug which is directly administered in the body should be sterile and particle free, so packaging plays important role in the parental drugs. Parental packaging is one of the important component of good manufacturing practices (cGMPs) in the manufacturing, so professional team and skilled labors are required for good aseptic practices (GAPs) in dispensing parental products to patients for administration.
Parenteral packaging market is classified into four major categories like product type, material type, packaging type and geography. Based on the product type parenteral packaging market is categorized into bottles, ampoules, vials, prefilled syringes, cartridges, and bags. Based on the material type market is classified into glass, plastic, polymer, PVC and others. Glass and plastic are the most common type of material used. Ampoules are only made of glass while all bags are made of a plastic. All other containers are made of either plastic or glass. On the basis of packaging type parenteral packaging market is classified into small volume packaging and large volume packaging. According to USP (United States Pharmacopeia) there are two types of glass used for parenteral packaging containers. Type I glass is a borosilicate glass and used for neutral preparation. Type II is soda lime glass and is used for packaging acidic alkaline and neutral parenteral preparations.
Geographically, the global parenteral packaging market has been classified into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America was a leading market for parenteral packaging, in terms of revenue, owing to increasing prevalence of chronic diseases and rising demand for sterile packaging. North America was followed by Europe in the same year. Emerging markets such as Asia Pacific, Latin America, and Middle East & Africa are expected to witness high growth from 2017 to 2025 due to increasing patient population and growing health care industry in these regions. Among developing countries, the market in South Korea, China, and India is expected to witness robust growth between 2017 and 2025, due to growing investments by governments of these countries to improve health care facilities.
Advancement and development in packaging solutions which deliver product quality, protection, patient comfort, and security needs are anticipated to surge consumer demands. This is projected to drive the market for innovative parenteral packaging. Furthermore, implementation and introduction of number of stringent standards and regulations for parenteral packaging by government and regulatory organizations such as Parenteral Drug Association (PDA), National Quality Forum (NQF), Healthcare Compliance Packaging Council (HCPC), and Food and Drug Administration (FDA) is anticipated to boost the growth of the market during the forecast period from 2017-2025. However, limited availability of raw materials and instability in the price of raw materials is estimated to hinder the growth of the market. Additionally, complex registration process of packaging is anticipated to be a restrain in the growth of the market
Key players operating in the parenteral packaging market include Gerresheimer AG, Unilife Corporation, Inc, Schott AG, Dickinson and Company, West Pharmaceutical Services, Inc., RPC Group, Ypsomed Holding AG, Terumo Corporation, SiO2 Medical Products, Ompi, Stevanato Group, Nipro Corporation, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois, Graphic Packaging Group, and Schott Pharmaceuticals Services Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.